SL2 ADVANCES IN MOLECULAR BIOLOGY AND GENETICS IN GLIOMA RESEARCH AND THERAPY

по Cavenee, Webster K
Опубликовано в: Neurooncol Adv (2019)

EL1 BUILDING A CAREER IN NEURO-ONCOLOGY RESEARCH

по Cavenee, Webster K
Опубликовано в: Neurooncol Adv (2019)

Stem Cells for Treating Glioblastoma: How Close to Reality?

по James, C. David, Cavenee, Webster K.
Опубликовано 2009

Regulation of cholesterol biosynthesis in HeLa S3G cells by serum lipoproteins: Dexamethasone-mediated interference with suppression of 3-hydroxy-3-methylglutaryl coenzyme A reduct...

по Cavenee, Webster K., Johnston, Dean, Melnykovych, George
Опубликовано 1978

mTORC2 dictates Warburg effect and drug resistance

по Masui, Kenta, Cavenee, Webster K, Mischel, Paul S
Опубликовано 2014

mTORC2 in the center of cancer metabolic reprogramming

по Masui, Kenta, Cavenee, Webster K., Mischel, Paul S.
Опубликовано 2014

mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment

по Masui, Kenta, Cavenee, Webster K., Mischel, Paul S.
Опубликовано в: Brain Pathol (2015)

Cancer metabolism as a central driving force of glioma pathogenesis

по Masui, Kenta, Cavenee, Webster K., Mischel, Paul S.
Опубликовано в: Brain Tumor Pathol (2016)

Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling

по Liu, Feng, Mischel, Paul S., Cavenee, Webster K.
Опубликовано в: NPJ Precis Oncol (2017)

Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations

по Wykosky, Jill, Fenton, Tim, Furnari, Frank, Cavenee, Webster K.
Опубликовано 2011

Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance

по Taylor, Tiffany E., Furnari, Frank B., Cavenee, Webster K.
Опубликовано 2012

Extracellular nutrients are required to maintain oncogenic signaling in brain cancer – a critical role for mTORC2

по Masui, Kenta, Shibata, Noriyuki, Cavenee, Webster K., Mischel, Paul S.
Опубликовано в: Bioessays (2016)

PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1

по Roeb, Wendy, Boyer, Antonia, Cavenee, Webster K., Arden, Karen C.
Опубликовано 2007

Arsenic reverses glioblastoma resistance to mTOR-targeted therapies

по Iwanami, Akio, Cloughesy, Timothy F., Cavenee, Webster K., Mischel, Paul S.
Опубликовано 2013

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma

по Furnari, Frank B., Cloughesy, Timothy F., Cavenee, Webster K., Mischel, Paul S.
Опубликовано в: Nat Rev Cancer (2015)

Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer

по Harachi, Mio, Masui, Kenta, Cavenee, Webster K., Mischel, Paul S., Shibata, Noriyuki
Опубликовано в: Metabolites (2021)

Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF(121) and VEGF(165) but not VEGF(189)

по Cheng, Shi-Yuan, Nagane, Motoo, Huang, H.-J. Su, Cavenee, Webster K.
Опубликовано 1997

Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain

по Furnari, Frank B., Lin, Hong, Huang, H.-J. Su, Cavenee, Webster K.
Опубликовано 1997

Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3

по Anderson, Michael J., Shelton, G. Diane, Cavenee, Webster K., Arden, Karen C.
Опубликовано 2001

Trypanosoma cruzi trans-sialidase: A potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase/Akt signaling

по Chuenkova, Marina V., Furnari, Frank B., Cavenee, Webster K., Pereira, Miercio A.
Опубликовано 2001